By Lauren Leavitt, M.D., Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health
Patients have been asking us about peptides for years. The questions used to come quietly, usually toward the end of an appointment. They came in louder over the last twelve months, and louder still in the last few weeks. The reason is straightforward. Twelve peptides that had been pulled out of compounding access in 2023 are returning to the list of substances that licensed compounding pharmacies can prepare with a physician’s prescription.
That is a real shift, and it is a fair time to lay out what these peptides actually do, who they may help, and where the limits sit. This is not a regulatory recap. It is a clinical guide for patients who want to understand the therapy options now available to them, written in the same way I would explain it to a patient in my Houston practice.
A short note before we get into specifics. None of the peptides discussed here are FDA approved as drugs. They are prescription therapeutics that licensed compounding pharmacies can prepare for a specific patient under a physician’s order. Every peptide therapy protocol I oversee at Amanecia starts with a clinical evaluation, labs where appropriate, and a conversation about whether the therapy actually fits the patient in front of me. Peptides are not a menu. They are medicine.
Why Peptides at All
Peptides are short chains of amino acids that act as signaling molecules in the body. Your body already makes peptides. Some regulate inflammation. Some support tissue repair. Some help control sleep, hormones, metabolism, or immune response. Therapeutic peptides borrow that same biology and concentrate the effect on a specific system.
The reason peptides have been getting attention is not hype. It is that several of these molecules have years of human and animal data showing useful effects in narrow areas: tissue repair after injury, recovery support, gut inflammation, mitochondrial health, sleep architecture, immune modulation. None of them are miracle drugs. Used carefully, in the right patient, with the right protocol, they can support outcomes that would otherwise be slow to reach.
The risks come from the wrong patient, the wrong dose, the wrong source, or the wrong combination. That is the part a good physician owns.
The Twelve Peptides Now Returning to Compounding Access
Below is a clinical overview of the twelve peptides on the April 15, 2026 503A revision, organized by what patients typically ask them to do. Effective date for compounding access is April 22, 2026. Some of these have stronger clinical support than others. I have tried to be honest about the difference.
Tissue repair, recovery, and skin
BPC-157 (Body Protection Compound)
Studied for tissue repair, gut lining health, tendon and ligament recovery, and reduction of localized inflammation. The most patient-asked peptide in our practice. Most useful as part of a structured recovery plan after injury, surgery, or in patients with persistent tendinopathy. Not a substitute for physical therapy or rehab. Works best alongside it.
TB-500 (Thymosin Beta-4 fragment)
Studied for muscle recovery, flexibility, and connective tissue repair. Often discussed alongside BPC-157 in recovery protocols. The clinical signal is strongest in the recovery space. Patients ask about it for chronic strain patterns, post-surgical healing, and sports recovery.
GHK-Cu (Copper Peptide)
Studied for skin remodeling, wound healing, and hair follicle support. Used both topically and as an injectable. Patients usually encounter this through skincare first and then ask whether the injectable form is worth considering. Best evaluated in the context of broader skin health and any underlying nutritional or hormonal contributors.
Metabolic, mitochondrial, and longevity
MOTS-C (Mitochondrial-Derived Peptide)
Studied for mitochondrial function, metabolic regulation, and cellular energy. The molecule of interest for patients focused on metabolic health, energy, and exercise capacity. Early-stage human data is interesting but limited. Useful as part of a coordinated metabolic plan that already addresses sleep, training, nutrition, and labs.
Epitalon
Studied as a pineal-derived peptide with potential effects on circadian rhythm and certain longevity markers. Frequently discussed in the longevity space. The data is earlier-stage and most of the human work comes from outside the U.S. Patients should treat it as exploratory rather than established.
Cognitive and neurological
Semax
A neuropeptide originally developed in Russia, studied for cognitive performance, focus, and neuroprotection. Some patients use it for periods of high cognitive demand. The U.S. clinical data is thin. Patients with anxiety, mood disorders, or who are on psychiatric medications should not pursue Semax without close coordination with their physician.
Dihexa
A peptide derivative studied for cognitive support and neural connectivity. Earlier-stage research, often discussed alongside Semax in the cognitive category. Not for patients seeking a quick mental edge. The right framing is exploratory, in patients without contraindications, and only inside a physician-led plan.
Sleep and recovery
DSIP (Delta Sleep-Inducing Peptide)
Studied for sleep architecture and stress response. Used by some patients dealing with sleep onset and maintenance issues that have not responded to lifestyle changes. Sleep is one of those areas where I want to rule out the underlying cause first, including hormones, stress, breathing, and medications, before adding a peptide on top.
Immune, inflammatory, and gut
KPV
A small anti-inflammatory peptide studied for gut inflammation, certain inflammatory skin conditions, and immune regulation. Patients with persistent low-grade gut symptoms sometimes ask about it. Most useful as part of a broader gut and inflammation plan, not in isolation.
LL-37
A naturally occurring antimicrobial peptide studied for immune modulation and antimicrobial activity. The clinical use case is narrower and depends heavily on the patient’s specific picture. Not a peptide I prescribe casually.
Muscle and growth signaling
PEG-MGF (Pegylated Mechano Growth Factor)
A modified form of mechano growth factor, studied for muscle repair and recovery. The patient interest comes mostly from athletes and recovery-focused patients. Earlier-stage research and a narrower use case. Best discussed in the context of an actual training and recovery plan.
Pigmentation and specialized use
Melanotan II
Studied for skin pigmentation and certain effects on libido and appetite. This one is included on the April 15 list, and we should be straightforward about it. Amanecia does not prescribe Melanotan II for cosmetic tanning. The risk profile, the side effect picture, and the lack of medical indication make it a different conversation than the recovery, metabolic, and immune peptides above. Patients curious about it should hear from a physician about what is actually known and what is not.
What This Means for You as a Patient
If any of the above describes a problem you are working on, the right next step is the same as it always is. Talk to a physician who knows your full picture. That includes your medications, your labs, your hormones, your sleep, your stress, and the things you have already tried.
What I do not want patients doing is ordering peptides off a website, using a dosing protocol they read on social media, and assuming a legal compounding category change makes any of that safer. The category change improves access through licensed pharmacies. It does not change the rules of careful medicine.
A few practical points if you are considering peptide therapy.
Sourcing matters. We work with FDA-registered, U.S.-based compounding pharmacies that comply with USP 797 and 795 standards. Not every pharmacy preparing peptides operates at the same level. Ask where your peptides come from.
Dosing matters. Peptides do not have a one-size-fits-all dose. Body size, baseline labs, what else you are taking, and what you are trying to accomplish all change the answer. Generic protocols from the internet ignore most of that.
Monitoring matters. The right peptide today may not be the right peptide three months from now. Good peptide therapy is iterative. We adjust based on response and labs, not based on what you read this week.
Integration matters. Peptide therapy works best inside a coordinated plan. Patients who pair it with sleep, training, nutrition, and the rest of their care see better outcomes than patients chasing one molecule in isolation.
How Amanecia Approaches Peptide Therapy
At Amanecia Health, peptide therapy is not a product on a checkout page. It is a treatment we evaluate, prescribe, source, monitor, and adjust. Every protocol is overseen by a board-certified Emergency Medicine physician.
Our standard process looks like this.
A real consultation. We start with your health history, your current medications, your labs, and what you are actually trying to accomplish. Some patients leave the first visit with a peptide plan. Others leave with a different plan, because the peptide was not the right tool for their problem.
Compliant pharmacy sourcing. We work with FDA-registered, U.S.-based compounding pharmacies that meet USP 797 and 795 standards. We do not source from gray-market suppliers, and we do not chase the cheapest vial.
Ongoing monitoring. We follow your response, look at relevant labs over time, and adjust dosing or switch protocols when the data tells us to.
Integration with the rest of your care. Peptides usually sit alongside hormone work, weight management, sleep, recovery, or longevity goals. A coordinated plan beats a stack of disconnected molecules.
Common Questions Patients Ask
Are these peptides FDA approved?
No. The April 15, 2026 503A revision allows licensed compounding pharmacies to prepare these twelve peptides under a physician’s prescription, effective April 22, 2026. They are not FDA-approved drugs and have not gone through the clinical trial process required for drug approval.
Is it safe to order peptides online?
No. Many online sources are unregulated. Quality, purity, dosing, and contamination are real concerns with gray-market suppliers. Peptides should be sourced through a physician and a licensed compounding pharmacy.
Which peptide is best for me?
That depends on what you are trying to accomplish, what your labs and history look like, and what else you are taking. There is not a universal answer. The first step is a real evaluation.
How long does peptide therapy usually last?
It depends on the peptide and the goal. Some recovery protocols are short and finite. Some metabolic or longevity protocols are longer and iterative. We do not put patients on indefinite open-ended protocols by default.
Will my insurance cover peptide therapy?
No. Compounded peptides are not covered by insurance. Amanecia operates on a direct-pay model. HSA and FSA payments are accepted for eligible services.
Do you treat patients outside Houston?
Yes. Amanecia Health serves patients across Austin, Houston, Dallas-Fort Worth, and Coastal Virginia through telemedicine and in-home visits. Our physicians are board-certified Emergency Medicine doctors.
The Bottom Line
The April 15 revision is good news for patients who can benefit from carefully managed peptide therapy. It is not a green light for self-prescribing or for treating peptides as supplements. The underlying clinical question has not changed. Is this the right molecule, at the right dose, from the right source, for this patient, inside a plan a physician is actually monitoring.
If you have been waiting on a clear conversation about whether peptide therapy fits your goals, this is a good time to have it.
Lauren Leavitt, M.D. is a board-certified Emergency Medicine physician and third-generation doctor with 15 years of clinical experience. She co-founded Amanecia Health and leads the Houston practice, serving patients across the greater Houston area through telemedicine and in-home visits.
Schedule a consultation with Dr. Leavitt or any Amanecia Health physician.
Compounded peptides are not FDA-approved drugs. They are prepared by licensed compounding pharmacies under physician prescription and have not been evaluated through clinical trials for safety, efficacy, or therapeutic equivalence to any FDA-approved medications. This content is for informational and educational purposes and does not constitute medical advice. Whether any specific peptide therapy is appropriate for a given patient depends on individual evaluation by a licensed physician.